AcelRx Pharmaceuticals(ACRX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling seven active sites Cash and investments at September 30, 2024 of $11.1 million Conference call and webcast to be held Wednesday, November 13, 2024 at 4:30 pm ET SAN MATEO, Calif., November 13, 2024 – Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), ...